Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 4 3Phase 3 2Phase 2 2Phase 1 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 1Breast Neoplasms 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Ethinyl Estradiol × Clear all
NCT03843736 2019-10-10

The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.

Peking Union Medical College Hospital

Phase 3 Unknown
200 enrolled

Polycystic Ovary Syndrome

NCT00193726 2018-09-20

Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

Tata Memorial Hospital

Phase 3 Terminated
273 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡